5. Mai 2014 AP

Caterna Vision GmbH closes a first round of financing with Peppermint VenturePartners

Berlin:
Caterna Vision GmbH, a company in the field of digital therapies for eye disorders, such as amblyopia, today reported the completion of a financing as part of a „first closing“ led by the Peppermint Charité Biomedical Fund (CBF-1) managed by Peppermint VenturePartners (PVP).